Finished
Clinical Outcomes and Prognostic Factors of Robotic Assisted Rectal Cancer Resection Alone vs. Robotic Rectal Cancer Resection With Natural Orifice Specimen Extraction
NCT04265417 · Taiyuan Li · Updated 18 Feb 2020
- What is being tested
- Robotic Assisted Rectal Cancer Resection Alone; Robotic Assisted Rectal Cancer Resection With Natural Orifice Specimen Extraction
- For
- Rectal Neoplasms; Robotic Surgery; Natural Orifice Specimen Extraction Surgery
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 98 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 6 Jan 2015, ends 1 Dec 2016. Registered 11 Feb 2020.
- Results
- None posted yet.
In the researchers' words
Robotic rectal cancer resection with natural orifice extraction is a recently developed minimally invasive surgery for patients with rectal cancer. However, it's safety and feasibility remain undiscussed and controversial. This study reported the clinical outcomes and prognostic factors of robotic assisted rectal cancer resection alone vs. robotic rectal cancer resection with natural orifice extraction to discuss aforementioned question.